Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1270
| Despition | Luteinizing Hormone Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1724 | Human FGF13 Protein (AC1724) | 5 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1662 | Human POFUT1 Protein (AC1662) | 5 µg | inquiry |
| ACPP-1353 | PDE7B Blocking Peptide (AC1353) | 250 µg | inquiry |
| ACPP-1757 | Human Artemin Protein (AC1757) | 5 µg | inquiry |
| ACPP-1246 | Bestrophin Blocking Peptide (AC1246) | 250 µg | inquiry |
| ACPP-1627 | Human Visfatin Protein, His (AC1627) | 5 µg | inquiry |
| ACPP-1437 | Human LINGO1 Protein (AC1437) | 5 µg | inquiry |
| ACPP-1720 | Human PNPO Protein (AC1720) | 5 µg | inquiry |
| ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.